Last 12 months
Inside the activity.
14 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 6 | 0 |
| Jun 2026 | 5 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC |
Scanlan Sean F.Chief Innovation Officer
|
GrantCommon Stock | 65,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001589 · doc4.xml · nonDerivative · entry 1 Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,209 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 96,070 RSUs. Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC |
Treace John T.Director · Chief Executive Offer · 10% owner
|
GrantCommon Stock | 178,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001590 · doc4.xml · nonDerivative · entry 1 Treace John T. · CIK 0001856380 · Director · Chief Executive Offer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,800,180 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 with the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 203,731 restricted stock units. Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC |
Hair MarkChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 104,600 | $0.00 Strike: $13.46 | $0.00 |
DisclosureSEC source: 0001209191-24-001591 · doc4.xml · derivative · entry 3 Hair Mark · CIK 0001725070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,600 Underlying: Stock Option (Right to Buy) · 104,600 shares Expires 2034-01-10 F3 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC |
Hair MarkChief Financial Officer
|
GrantCommon Stock | 92,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001591 · doc4.xml · nonDerivative · entry 1 Hair Mark · CIK 0001725070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,810 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 147,662 RSUs. Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC |
Berutti AaronSr. VP, Sales
|
GrantStock Option (Right to Buy) · Derivative | 73,200 | $0.00 Strike: $13.46 | $0.00 |
DisclosureSEC source: 0001209191-24-001593 · doc4.xml · derivative · entry 2 Berutti Aaron · CIK 0001871334 · Sr. VP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,200 Underlying: Stock Option (Right to Buy) · 73,200 shares Expires 2034-01-10 F3 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC |
Berutti AaronSr. VP, Sales
|
GrantCommon Stock | 65,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001593 · doc4.xml · nonDerivative · entry 1 Berutti Aaron · CIK 0001871334 · Sr. VP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,867 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and with the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 103,787 RSUs. Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC |
Elder Scot Michael*See "Remarks"
|
GrantStock Option (Right to Buy) · Derivative | 69,050 | $0.00 Strike: $13.46 | $0.00 |
DisclosureSEC source: 0001209191-24-001592 · doc4.xml · derivative · entry 2 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,050 Underlying: Stock Option (Right to Buy) · 69,050 shares Expires 2034-01-10 F3 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC |
Elder Scot Michael*See "Remarks"
|
GrantCommon Stock | 61,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001592 · doc4.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,210 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 105,932 RSUs. Read SEC document |
| November 02, 2023 Filed Nov 4, 2023 01:00 UTC |
Scanlan Sean F.Chief Innovation Officer
|
Tax withholdingCommon Stock | 211 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054433 · doc4.xml · nonDerivative · entry 1 Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,184 F1 · balance_after: Includes 31,045 RSUs. Read SEC document |
| November 02, 2023 Filed Nov 4, 2023 01:00 UTC |
Elder Scot Michael*See "Remarks"
|
Tax withholdingCommon Stock | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054434 · doc4.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,910 F1 · balance_after: Includes 44,632 RSUs. Read SEC document |
| October 03, 2023 Filed Oct 6, 2023 01:00 UTC |
Elder Scot Michael*See "Remarks"
|
Tax withholdingCommon Stock | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052266 · doc4.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,519 F1 · balance_after: Includes 45,241 RSUs. Read SEC document |
| June 05, 2023 Filed Jun 8, 2023 16:28 UTC |
BAYS F BARRYFormer Director
|
SaleCommon Stock | 1,042,318 | $26.51 | $27,631,850.18 |
DisclosureSEC source: 0001209191-23-035400 · doc4.xml · nonDerivative · entry 2 BAYS F BARRY · CIK 0001183554 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 02, 2023 Filed Jun 8, 2023 16:28 UTC |
BAYS F BARRYFormer Director
|
SaleCommon Stock | 48,503 | $26.51 | $1,285,814.53 |
DisclosureSEC source: 0001209191-23-035400 · doc4.xml · nonDerivative · entry 1 BAYS F BARRY · CIK 0001183554 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,042,318 Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC |
Hanna BetsyDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,305 | $0.00 Strike: $26.34 | $0.00 |
DisclosureSEC source: 0001209191-23-032353 · doc4.xml · derivative · entry 2 Hanna Betsy · CIK 0001885957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,305 Underlying: Common Stock · 6,305 shares Expires 2033-05-23 F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC |
Hanna BetsyDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032353 · doc4.xml · nonDerivative · entry 1 Hanna Betsy · CIK 0001885957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,235 F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer. F2 · balance_after: Includes 3,940 RSUs. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC |
Berry Lance ADirector
|
GrantStock Option (Right to Buy) · Derivative | 6,305 | $0.00 Strike: $26.34 | $0.00 |
DisclosureSEC source: 0001209191-23-032352 · doc4.xml · derivative · entry 2 Berry Lance A · CIK 0001478716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,305 Underlying: Common Stock · 6,305 shares Expires 2033-05-23 F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC |
Berry Lance ADirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032352 · doc4.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,585 F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer. F2 · balance_after: Includes 5,585 RSUs. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC |
BAKEWELL JOHN KDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,305 | $0.00 Strike: $26.34 | $0.00 |
DisclosureSEC source: 0001209191-23-032354 · doc4.xml · derivative · entry 4 BAKEWELL JOHN K · CIK 0001183553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,305 Underlying: Common Stock · 6,305 shares Expires 2033-05-23 F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC |
BAKEWELL JOHN KDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032354 · doc4.xml · nonDerivative · entry 1 BAKEWELL JOHN K · CIK 0001183553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,048 F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date. F2 · balance_after: Includes 2,753 RSUs. Read SEC document |
| May 23, 2023 Filed May 25, 2023 21:00 UTC |
MOTT RICHARD WDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,305 | $0.00 Strike: $26.34 | $0.00 |
DisclosureSEC source: 0001209191-23-032351 · doc4.xml · derivative · entry 2 MOTT RICHARD W · CIK 0001210226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,305 Underlying: Common Stock · 6,305 shares Expires 2033-05-23 F4 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 23, 2023 Filed May 25, 2023 21:00 UTC |
MOTT RICHARD WDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032351 · doc4.xml · nonDerivative · entry 1 MOTT RICHARD W · CIK 0001210226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 907,753 F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · price: Includes 2,753 RSUs. F3 · balance_after: Includes 2,753 RSUs. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC |
HAMILTON LAWRENCE WDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,305 | $0.00 Strike: $26.34 | $0.00 |
DisclosureSEC source: 0001209191-23-032355 · doc4.xml · derivative · entry 2 HAMILTON LAWRENCE W · CIK 0001326586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,305 Underlying: Common Stock · 6,305 shares Expires 2033-05-23 F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC |
Kiernan Jane EDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,305 | $0.00 Strike: $26.34 | $0.00 |
DisclosureSEC source: 0001209191-23-032350 · doc4.xml · derivative · entry 2 Kiernan Jane E · CIK 0001379171 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,305 Underlying: Common Stock · 6,305 shares Expires 2033-05-23 F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC |
Kiernan Jane EDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032350 · doc4.xml · nonDerivative · entry 1 Kiernan Jane E · CIK 0001379171 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,585 F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer. F2 · balance_after: Includes 5,585 RSUs. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC |
Jain DeeptiDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,305 | $0.00 Strike: $26.34 | $0.00 |
DisclosureSEC source: 0001209191-23-032349 · doc4.xml · derivative · entry 2 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,305 Underlying: Common Stock · 6,305 shares Expires 2033-05-23 F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC |
Jain DeeptiDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032349 · doc4.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,235 F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. F2 · balance_after: Includes 3,940 RSUs. Read SEC document |
| May 16, 2023 Filed May 19, 2023 01:00 UTC |
Scanlan Sean F.Chief Innovation Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001209191-23-030857 · doc4.xml · derivative · entry 3 Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,750 Underlying: Common Stock · 25,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The stock option vested in equal annual installments over 4 years, commencing on December 15, 2015 with the last installment vesting on December 15, 2018. Read SEC document |
| May 16, 2023 Filed May 19, 2023 01:00 UTC |
Scanlan Sean F.Chief Innovation Officer
|
SaleCommon Stock | 25,000 | $25.44 | $635,977.50 |
DisclosureSEC source: 0001209191-23-030857 · doc4.xml · nonDerivative · entry 2 Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,395 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0600 to $25.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 31,256 RSUs. Read SEC document |
| May 16, 2023 Filed May 19, 2023 01:00 UTC |
Scanlan Sean F.Chief Innovation Officer
|
Exercise / conversionCommon Stock | 25,000 | $0.10 | $2,500.00 |
DisclosureSEC source: 0001209191-23-030857 · doc4.xml · nonDerivative · entry 1 Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 31,256 RSUs. Read SEC document |
| May 01, 2023 Filed May 2, 2023 21:00 UTC |
TREACE JAMES TDirector
|
SaleCommon Stock | 2,360 | $25.91 | $61,148.31 |
DisclosureSEC source: 0001209191-23-026796 · doc4.xml · nonDerivative · entry 3 TREACE JAMES T · CIK 0001185191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 861,441 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5400 to $26.1500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2023 Filed May 2, 2023 21:00 UTC |
TREACE JAMES TDirector
|
SaleCommon Stock | 7,640 | $25.04 | $191,282.68 |
DisclosureSEC source: 0001209191-23-026796 · doc4.xml · nonDerivative · entry 2 TREACE JAMES T · CIK 0001185191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 863,801 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.5400 to $25.5000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 28, 2023 Filed May 2, 2023 21:00 UTC |
TREACE JAMES TDirector
|
SaleCommon Stock | 40,000 | $25.01 | $1,000,264.00 |
DisclosureSEC source: 0001209191-23-026796 · doc4.xml · nonDerivative · entry 1 TREACE JAMES T · CIK 0001185191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 871,441 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.4100 to $25.3050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 27, 2023 Filed Apr 28, 2023 21:00 UTC |
BAYS F BARRYDirector
|
SaleCommon Stock | 11,600 | $25.35 | $294,031.00 |
DisclosureSEC source: 0001209191-23-026167 · doc4.xml · nonDerivative · entry 2 BAYS F BARRY · CIK 0001183554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,090,821 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.1500 to $25.6950 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 21:00 UTC |
BAYS F BARRYDirector
|
SaleCommon Stock | 16,204 | $25.55 | $414,012.20 |
DisclosureSEC source: 0001209191-23-026167 · doc4.xml · nonDerivative · entry 1 BAYS F BARRY · CIK 0001183554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,102,421 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.4400 to $25.7850 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 12, 2023 Filed Apr 13, 2023 21:00 UTC |
BAYS F BARRYDirector
|
SaleCommon Stock | 36,370 | $26.12 | $950,104.42 |
DisclosureSEC source: 0001209191-23-024260 · doc4.xml · nonDerivative · entry 3 BAYS F BARRY · CIK 0001183554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,118,625 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.8400 to $26.5050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 21:00 UTC |
BAYS F BARRYDirector
|
SaleCommon Stock | 5,026 | $27.28 | $137,108.27 |
DisclosureSEC source: 0001209191-23-024260 · doc4.xml · nonDerivative · entry 2 BAYS F BARRY · CIK 0001183554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,154,995 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.1500 to $27.5700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 21:00 UTC |
BAYS F BARRYDirector
|
SaleCommon Stock | 44,764 | $26.28 | $1,176,286.01 |
DisclosureSEC source: 0001209191-23-024260 · doc4.xml · nonDerivative · entry 1 BAYS F BARRY · CIK 0001183554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,160,021 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0100 to $26.9700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 21:00 UTC |
MOTT RICHARD WDirector
|
SaleCommon Stock | 4,043 | $26.00 | $105,121.23 |
DisclosureSEC source: 0001209191-23-023948 · doc4.xml · nonDerivative · entry 1 MOTT RICHARD W · CIK 0001210226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 905,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 2,295 RSUs. Read SEC document |
| April 04, 2023 Filed Apr 5, 2023 21:00 UTC |
MOTT RICHARD WDirector
|
SaleCommon Stock | 15,756 | $26.00 | $409,667.03 |
DisclosureSEC source: 0001209191-23-023543 · doc4.xml · nonDerivative · entry 2 MOTT RICHARD W · CIK 0001210226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 909,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.9050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 2,295 RSUs. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 21:00 UTC |
MOTT RICHARD WDirector
|
SaleCommon Stock | 201 | $26.00 | $5,226.00 |
DisclosureSEC source: 0001209191-23-023543 · doc4.xml · nonDerivative · entry 1 MOTT RICHARD W · CIK 0001210226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 924,799 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 2,295 RSUs. Read SEC document |
| March 31, 2023 Filed Mar 31, 2023 21:00 UTC |
MOTT RICHARD WDirector
|
SaleCommon Stock | 95,000 | $25.36 | $2,409,029.00 |
DisclosureSEC source: 0001209191-23-021956 · doc4.xml · nonDerivative · entry 2 MOTT RICHARD W · CIK 0001210226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 925,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.9050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 2,295 RSUs. Read SEC document |
| March 30, 2023 Filed Mar 31, 2023 21:00 UTC |
TREACE JAMES TDirector
|
SaleCommon Stock | 50,000 | $25.86 | $1,293,170.00 |
DisclosureSEC source: 0001209191-23-021955 · doc4.xml · nonDerivative · entry 1 TREACE JAMES T · CIK 0001185191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 911,441 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5100 to $26.0700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 30, 2023 Filed Mar 31, 2023 21:00 UTC |
MOTT RICHARD WDirector
|
SaleCommon Stock | 38,498 | $26.00 | $1,000,998.05 |
DisclosureSEC source: 0001209191-23-021956 · doc4.xml · nonDerivative · entry 1 MOTT RICHARD W · CIK 0001210226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,020,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 2,295 RSUs. Read SEC document |
| March 29, 2023 Filed Mar 30, 2023 21:00 UTC |
BAYS F BARRYDirector
|
SaleCommon Stock | 32,457 | $25.28 | $820,425.33 |
DisclosureSEC source: 0001209191-23-021741 · doc4.xml · nonDerivative · entry 2 BAYS F BARRY · CIK 0001183554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,204,785 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0900 to $25.5600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 21:00 UTC |
BAYS F BARRYDirector
|
SaleCommon Stock | 26,241 | $25.02 | $656,649.54 |
DisclosureSEC source: 0001209191-23-021741 · doc4.xml · nonDerivative · entry 1 BAYS F BARRY · CIK 0001183554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,237,242 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.8800 to $25.1600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 23, 2023 Filed May 26, 2023 01:00 UTC |
HAMILTON LAWRENCE WDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032355 · doc4.xml · nonDerivative · entry 1 HAMILTON LAWRENCE W · CIK 0001326586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,048 F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer. F2 · balance_after: Includes 2,753 RSUs. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:00 UTC |
Owens Daniel E.Chief Human Resources Officer
|
Exercise / conversionStock Option Right to Buy · Derivative | 6,250 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001209191-23-019944 · doc4.xml · derivative · entry 3 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,375 Underlying: Stock Option Right to Buy · 6,250 shares Expires 2031-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:00 UTC |
Owens Daniel E.Chief Human Resources Officer
|
SaleCommon Stock | 6,250 | $22.87 | $142,955.63 |
DisclosureSEC source: 0001209191-23-019944 · doc4.xml · nonDerivative · entry 2 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,914 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.6600 to $23.3900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 25,650 RSUs. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:00 UTC |
Owens Daniel E.Chief Human Resources Officer
|
Exercise / conversionCommon Stock | 6,250 | $7.03 | $43,925.00 |
DisclosureSEC source: 0001209191-23-019944 · doc4.xml · nonDerivative · entry 1 Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 25,650 RSUs. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:00 UTC |
TIMBIE THOMAS EDirector
|
SaleCommon Stock | 50,000 | $23.03 | $1,151,665.00 |
DisclosureSEC source: 0001209191-23-019943 · doc4.xml · nonDerivative · entry 1 TIMBIE THOMAS E · CIK 0001188309 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001 Disclosed balance after: 1,149,069 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.7500 to $23.4300 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.